Abstract:Due to the complexity and variability of the cellular metabolic process and the physiological environment inside and outside the cell, higher requirements are needed on the application of DNA molecular logic gate in cell analysis. In addition, heterogeneity of tumor cells tends to lead to false positives in the clinical diagnosis of a single target, even those with the same cancer type. To address these issues above, we have developed a novel DNA molecular logic gate responsive nanomachine for bispecific recognition and computation of cell membranes. Only when two membrane proteins, MUC1 and EpCAM as model proteins, exist simultaneously, the DNA molecular logic gate can be activated to perform "AND" logic operation and generate amplified "ON" fluorescence signal from the cell membrane. Therefore, our proposed dual-specific "recognition-biocomputing" DNA molecular logic gate has achieved highly accurate imaging analysis of dual-target membrane proteins in situ. Furthermore, the logic gate responsive DNA nanomachine can also be used to analyze target cells in complex cell samples with excellent specificity, which will meet the needs of biomedicine and their application in clinical diagnosis and provide new tools for the biomedical application of DNA molecular logic gates in complex cell systems.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.0c01166?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.0c01166</a>.Sequences of DNA oligonucleotides used in this work (Table S1). Schematic diagram of the digestion of PA1 by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase for 0–60 min (Figure S1). Schematic diagram of the digestion of PA1-CT by phi29 DNA polymerase and digestion of 1 μM PA1 by phi29 DNA polymerase in the presence of 0–2.5 μM CT (Figure S2). Immunofluorescence of mucin (MUC1) from three cell lines and immunofluorescence of epithelial adhesion molecules (EpCAM) from three cell lines. Scale bar = 20 μm (Figure S3). Western blotting results of MUC1 and EpCAM expression from three cell lines (Figure S4). Fluorescence microscopy images of MCF-7 cells incubated in DNA nanomachine for different times (0–90 min). Scale bar = 20 μm (Figure S5). Fluorescence microscopy images and fluorescence intensity statistics of different rolling circle amplification times after the interaction of DNA nanomachine with the cell membrane surface. Scale bar = 20 μm (Figure S6). Schematic diagram of fluorophore-labeled DNA ternary complex, fluorescence intensity analysis of assembly of fluorophore-labeled DNA ternary complex, and confocal laser scanning microscopy images of three cell lines incubated with fluorophore-labeled DNA nanomachine. Scale bar = 20 μm (Figure S7). Study on the amplification efficiency of logic gate responsive DNA nanomachine. Confocal laser scanning microscopy images of MCF-7 cells incubated with different DNA assemblies: (A) green fluorescence (FAM) and (B) red fluorescence (Cy5). (C, D) Fluorescence intensity statistics of cell imaging from (A) and (B) by ImageJ software. Scale bar = 20 μm (Figure S8) (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.0c01166/suppl_file/se0c01166_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Cerasome Spherical Nucleic Acid Nanostructure-Based AND Logic Gate-Guided Dual-DNAzyme Walker for Accurate Cancer Cell Identification

Endogenous AND Logic DNA Nanomachine for Highly Specific Cancer Cell Imaging

Dual-Locked DNAzyme Platform for In Vitro and In Vivo Discrimination of Cancer Cells

A "dual-key-and-lock" DNA nanodevice enables spatially controlled multimodal imaging and combined cancer therapy

Construction of a DNA walker nanomachine aptasensor for simultaneous detection of dual-cancer biomarkers

Intelligent Reconfiguration‐Promoted Cellular Internalization of Core–Shell DNA Nanoprobe Equipped with Successive Dual Stimuli‐Responsive Protective Satellites for Amplification Fluorescence Imaging of Tumor Cells

DNA Nanomachine-Based Regenerated Sensing Platform: a Novel Electrochemiluminescence Resonance Energy Transfer Strategy for Ultra-High Sensitive Detection of Microrna from Cancer Cells.

DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions

A rapid dual-mode SERS/FL cytosensor assisted via DNA Walker-based plasmonic nanostructures

An advanced 3D DNA nanoplatform for spatiotemporally confined enhanced dual-mode biosensing MicroRNA in cancer cell

DNA Walker Induced “signal Off” Electrochemical Cytosensor Strategy for Ultrasensitive Detection of Tumor Cells

Ultrasensitive Detection of Circulating Tumor Cells Via DNA Walker Driven by a DNA Circuit Synergized with MOF-on-MOF Nanozyme

Near-Infrared Light-Powered and DNA Nanocage-Confined Catalytic Hairpin Assembly Nanobiosensor with a Nucleic Acid Restriction Behavior and Reinforced Enzymatic Resistance for Robust Imaging Assay in Live Biosystems

Synergistic powering of DNA walker movement by endogenous dual enzymes for constructing dual-mode biosensors

DNA Nanospheres Assisted Spatial Confinement Signal Amplification for MicroRNA Imaging in Live Cancer Cells

Logic Signal Amplification System for Sensitive Electrochemiluminescence Detection and Subtype Identification of Cancer Cells

Cell Membrane-Anchored AND Logic Gate Aptasensor for Tumor Cell-Specific Imaging with Improved Accuracy

Two-wheel Drive-Based DNA Nanomachine and Its Sensing Potential for Highly Sensitive Analysis of Cancer-Related Gene

Construction of a Ternary Complex Based DNA Logic Nanomachine for a Highly Accurate Imaging Analysis of Cancer Cells

Ph-Stimulated Self-Locked DNA Nanostructure for the Effective Discrimination of Cancer Cells and Simultaneous Detection and Imaging of Endogenous Dual-MicroRNAs.

DNA walker-powered SERS logic aptasensors for accurate imaging and identification of tumor cells